Top 50 Life Science Startup Investors in Canada (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
FACIT
VC Fund
|
9 | Canada, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Medical Device | $1.5M–$35M |
|
StandUp Ventures
VC Fund
|
7 | Canada, United States | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $317k–$14M |
|
Amplitude Venture Capital
VC Fund
|
6 | Canada, United States, Israel | Series B, Series A, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$142M |
|
Anges Quebec
VC Fund
|
6 | Canada, Spain, United States | Seed, Angel | Software, Health Care, Artificial Intelligence | $376k–$3.4M |
|
Real Ventures
VC Fund
|
6 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $700k–$50M |
|
Panache Ventures
VC Fund
|
6 | Canada, United States, Israel | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $713k–$20M |
|
BDC Venture Capital
VC Fund
|
5 | Canada, United States, Japan | Series A, Seed | Software, Information Technology, Artificial Intelligence | $600k–$20M |
|
Golden Ventures
VC Fund
|
5 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$49M |
|
E-Fund
VC Fund
|
5 | Canada, China, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $279k–$4.2M |
|
Pallasite Ventures
VC Fund
|
5 | Canada, United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $750k–$115M |
|
Toronto Innovation Acceleration Partners
VC Fund
|
5 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Biotechnology, Software | $13k–$8M |
|
Fonds de solidarité FTQ
VC Fund
|
5 | Canada, United States, Israel | Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Health Care | $500k–$50M |
|
Radical Ventures
VC Fund
|
4 | United States, Canada, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $2M–$200M |
|
Apjohn ventures
VC Fund
|
4 | United States, Canada | Series A, Series C | Health Care, Biotechnology, Life Science | $2.5M–$39M |
|
Ontario Centre of Innovation
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Medical, Software | $7.3k–$3.2M |
|
MaRS Investment Accelerator Fund
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Series A | Software, Health Care, Analytics | $368k–$14M |
|
MEDTEQ+
VC Fund
|
3 | Canada, United States | Seed, Series A, Venture - Series Unknown | Health Care, Medical Device, Biotechnology | $1.5M–$20M |
|
Lumira Ventures
VC Fund
|
3 | United States, Canada | Series A, Series B | Biotechnology, Health Care, Medical | $2.9M–$105M |
|
Ramen Ventures
VC Fund
|
3 | Canada, United States | Seed, Pre-Seed, Angel | Software, Biotechnology, Health Care | $120k–$3.2M |
|
Sustainable Development Technology Canada
VC Fund
|
3 | Canada, United States, Brazil | Grant, Seed, Pre-Seed | Manufacturing, Energy, Renewable Energy | $73k–$7.4M |
|
iGan Partners
VC Fund
|
3 | Canada, United States, Israel | Seed, Series A, Venture - Series Unknown | Health Care, Software, Medical | $500k–$17M |
|
Archangel Network of Funds
VC Fund
|
3 | Canada, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Medical Device | $10k–$19M |
|
Inovia Capital
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1M–$65M |
|
Afore Capital
VC Fund
|
3 | United States, Canada, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $500k–$25M |
|
Innovacorp
VC Fund
|
3 | Canada, Australia, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | $18k–$3.1M |
|
Graphite Ventures
VC Fund
|
3 | Canada, United States | Seed, Series A, Pre-Seed | Software, Health Care, Artificial Intelligence | $729k–$31M |
|
BDC Capital’s Women in Technology Venture Fund
VC Fund
|
3 | Canada | Series A, Series B, Venture - Series Unknown | Software, Artificial Intelligence, SaaS | $2.6M–$200M |
|
WUTIF
VC Fund
|
3 | Canada | Seed, Pre-Seed | Software, Health Care, Biotechnology | $100k–$3.8M |
|
GreenSky Ventures
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Artificial Intelligence | $709k–$12M |
|
OrganiGram
VC Fund
|
3 | Canada, United States, Germany | Convertible Note, Series B, Debt Financing | Cannabis, Biotechnology, Medical | $1M–$12M |
|
Page One Ventures
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed, Series B | Software, Artificial Intelligence, Information Technology | $500k–$130M |
|
Hazelview Ventures
VC Fund
|
2 | Canada, Slovakia (Slovak Republic) | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Big Data | $2M–$12M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $281k–$115M |
|
Western Technology Investment
VC Fund
|
2 | United States, Canada, Nigeria | Seed, Series A, Series B | Software, Health Care, Information Technology | $1M–$100M |
|
ScaleGood Fund LP (powered by TELUS)
VC Fund
|
2 | Canada | Seed, Pre-Seed | Health Care, Wellness, Apps | $37k–$8.7M |
|
Tom Williams
Angel
|
2 | United States, Canada, India | Seed, Series A, Series B | Software, Artificial Intelligence, Financial Services | $1.3M–$57M |
|
LVL1 Group
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Series A, Convertible Note | Software, Health Care, E-Commerce | $500k–$46M |
|
OurCrowd
VC Fund
|
2 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $604k–$65M |
|
Toyota Ventures
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Seed, Series B | Artificial Intelligence, Software, Robotics | $1.4M–$126M |
|
Killick Capital
VC Fund
|
2 | Canada, United States | Seed, Pre-Seed | Software, Health Care, Aerospace | $213k–$10M |
|
Theodorus III
VC Fund
|
2 | Belgium, Canada, France | Series A, Seed, Venture - Series Unknown | Health Care, Biotechnology, Software | $566k–$41M |
|
Bee Partners
VC Fund
|
2 | United States, Canada, India | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, E-Commerce | $500k–$25M |
|
Innovate Calgary
VC Fund
|
2 | Canada, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $48k–$2.1M |
|
Pfizer Venture Investments
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$120M |
|
Brigus Capital
VC Fund
|
2 | Canada, United States | Private Equity, Post-IPO Equity, Seed | Mining, Mineral, Health Care | $332k–$700k |
|
OS Fund
VC Fund
|
2 | United States, Canada | Series A, Seed, Series B | Biotechnology, Health Care, Health Diagnostics | $1.6M–$53M |
|
Gradient
VC Fund
|
2 | United States, Canada, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2.5M–$68M |
|
Builders VC
VC Fund
|
2 | United States, Canada, Mexico | Seed, Series A, Series B | Software, SaaS, Biotechnology | $1.8M–$39M |
|
Amplify Capital
VC Fund
|
2 | Canada, United States, India | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Education | $1.2M–$28M |
|
Coughdrop Capital
VC Fund
|
2 | United States, Canada | Seed, Pre-Seed | Software, Artificial Intelligence, FinTech | $125k–$9M |
| Access all 385 investors in Canada Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 31
- Round size: Seed $1.5M–$8M; Series A $11M–$35M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
- Hyivy Health — Hyivy Health is working on the first smart pelvic health rehabilitation system for patients and the clinicians who treat them.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
StandUp Ventures is a venture capital firm investing in female-founded companies in the B2B software and digital health sector.The firm is led by a team of experienced investors who have assembled a diverse advisory committee. The advisory committee is comprised of successful founders, venture investors, and other strategic mentors who willprovide high-touch support to the entrepreneurs. StandUp Ventures catalyzes strong deal flow across Canada from its network and syndicate seed rounds with Angels and US VCs.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 51
- Round size: Seed $1.3M–$5M; Pre-Seed $317k–$2M; Series A $2.3M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $16M in 2019
Portfolio highlights
- Wygo — This is why you've gotta go outside.
- GridBank — Enhance Your Social Media Engagement And Following With Stunning User-Generated Videos. Access A Wide Range Of Royalty-Free Stock Videos For Various Themes Including Travel, Productivity, Aesthetic Backgrounds, And More
- Pluvo — Financial forecasts calling for dry, complicated spreadsheets? Reclaim your time - no broken formulas, no duplication, no problems. Pluvo centralizes your data for dynamic scenario planning and unlimited forecasting!
Amplitude Ventures is a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology. and AI
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 37
- Round size: Seed $7M–$18M; Series A $3.2M–$85M; Series B $35M–$142M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $193M in 2024
Portfolio highlights
- Thryv Therapeutics — LQT Therapeutics is a biopharmaceutical company discovering and developing SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular diseases and cancers.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- Congruence Therapeutics — ABOUT US We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry. Our Science Traditional drug design is limited At Congruence,
Value-added investors for innovative entrepreneurs.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Angel
- Geography: Canada, Spain, United States
Investor stats
- Total investments: 174
- Round size: Seed $803k–$3.4M; Angel $376k–$1.3M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- SELL IT9 — Get top cash for your tech with SELLIT9, Canada's trusted trade-in service. Free same-day pickups, convenient drop-off locations, and pre-paid shipping labels nationwide. Fast, secure, and hassle-free!
- Solving.AI — Solving.AI is an AI training platform that helps in solving business software adoption issues.
- Elisa Interactive — Elisa Interactive operates an asset-light, prompt-to-environment software model designed to lower technical entry barriers in user-generated gaming ecosystems. Its core application platform, Me-Z-Scene, utilizes artificial intelligence to automatically arrange existing asset kits into complex 3D worlds based on natural language inputs. Thecompany's value proposition centers on empowering casual gamers and amateur builders to deploy custom virtual spaces without requiring coding or digital design expertise.
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 276
- Round size: Seed $700k–$5M; Series A $3.1M–$24M; Series B $2.9M–$50M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $140M in 2017
Portfolio highlights
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
- SPARK Microsystems — SPARK Microsystems delivers Low Energy Ultra-Wideband (LE-UWB) technology with ultra-low latency, high data throughput, and revolutionary power efficiency.
Canada's leading nationwide pre-seed venture fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 159
- Round size: Seed $912k–$6M; Pre-Seed $713k–$2.5M; Series A $6.3M–$20M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Proof — Make Government Decisions, Better.
- Ranger AI — Discover how Ranger RFX simplifies proposals with innovative tools designed for manufacturers. Improve accuracy, reduce downtime, and achieve cost savings today.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Canada, United States, Japan
Investor stats
- Total investments: 527
- Round size: Seed $600k–$4.9M; Series A $2.7M–$20M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $500M in 2022
Portfolio highlights
- Spark — Spark provides the platform required to sell, market, close and report on your entire portfolio of new development projects.
- WhatsNexx — Sujintoto adalah situs slot online yang memberikan pelayanan deposit yang sat set dan withdraw cepet selama 24 jam
- Neurio Technology — Neurio makes ordinary appliances smart and homes more efficient by letting you know what’s going on, when you need to know it - like if you forgot to turn off your stove, when your kids are home from school, and if they’re watching TV when they should be doing homework. With a Neurio sensor, our smartphone apps let you know what’s happening inyour home, which appliances are in use and the amount of energy they use without having to install sensors at every device.
Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 196
- Round size: Seed $1.5M–$7.5M; Series A $6.8M–$32M; Series B $14M–$49M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $103M in 2024
Portfolio highlights
- Space — Space is a cloud filesystem that appears in Finder as a regular drive. Open and save files with the apps that are used in regular basis while Space keeps them in the cloud and up to date across the Macs. So that one can work with terabytes of files without filling the computer or carrying external drives.
- Terminal — Easily add 30+ telematics integrations to your application with a single API. Connect your application to the services you need, without worrying about the underlying details
- Powered by People — Powered by People is a values-driven wholesale platform featuring handmade, ethical products from makers in over 40 countries. Sign up now for pre-approved credit and net 60 terms at poweredbypeople.com
The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, China, United States
Investor stats
- Total investments: 62
- Round size: Seed $474k–$4.2M; Pre-Seed $279k–$1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Qase — Qase helps law firms and legal referral organizations streamline referrals, automate intake and booking, and collect forwarding fees online.
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
Pallasite Ventures is an agile venture capital firm providing early-stage financing for high-growth companies across a variety of industries.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 38
- Round size: Seed $750k–$5M; Series A $3.2M–$20M; Series B $14M–$115M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ionomr — Ionomr designs & manufactures advanced ion-exchange polymers & membranes that enable high performance and efficiency in applications like water & wastewater treatment, hydrogen production and advanced energy storage.
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- Aspect Biosystems — Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 87
- Round size: Seed $73k–$8M; Grant $13k–$100k; Pre-Seed $22k–$525k
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
- Grey Matter Neurosciences — Empowering seniors to restore brain function through the unique power of focused ultrasound.
Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 267
- Round size: Series A $6M–$50M; Venture - Series Unknown $500k–$40M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Metal 7 —
- Namakor Holdings — We combine strategic investment and in-house operational expertise to untap the true potential of your industrial manufacturing businessNamakor Holdings is a private equity firm investing in mid-market manufacturing companies, driving growth, innovation, and global expansion.
- Premier Tech — Premier Tech has been focusing on skills development and recognition to constantly innovate, improve its operational excellence and deploy products and services that create value for its customers.
Radical Ventures is an early-stage venture capital firm investing in entrepreneurs applying deep technology to transform massive industries.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 135
- Round size: Seed $2M–$27M; Series A $7M–$83M; Series B $30M–$200M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $250M in 2026
Portfolio highlights
- Emerald AI — Intelligence to transform energy-intensive AI data centers into AI-powered grid allies
- Muon Space — Earth intelligence for a Safe and Resilient World.
- Generalist AI — At Generalist, we are on a mission to build general intelligence for the physical world.
Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstandinggrowth potential.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Life Science
- Stage:Series A, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 15
- Round size: Series A $2.5M–$39M; Series C $3M–$34M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Tetra Discovery — Tetra Discovery Partners provides consulting services in drug discovery and development. They partner with Universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system.Their research focuses on developing new treatments for depression and schizophrenia. Severe forms ofdepression affect 2–5% of the US population, while mood disorders impact 7% of the world’s population and rank among the top ten causes of disability.
- Tetra Therapeutics — Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders.
- Sierra Oncology — Sierra Oncology is late-stage clinical drug development biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer.
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 52
- Round size: Seed $366k–$3.2M; Grant $7.3k–$110k; Pre-Seed $151k–$2.5M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Synakis — Own synakis.com today. Secure checkout and guided transfer support. No hidden fees.
- Script Runner — Script Runner provides AI-powered prescription delivery and logistics software for pharmacies and healthcare providers. The platform enables pharmacies and hospitals to manage last-mile prescription delivery using in-house drivers, Script Runner’s driver network, or integrated services such as Uber Direct. It supports route planning, ordertracking, and drone-based recurring deliveries for medications within defined distances. The software includes tools for secure payment collection at the door or online, along with data security and storage aligned with industry compliance standards. Script Runner also offers virtual care and virtual prescribing capabilities for minor ailments bundled with delivery, helping providers coordinate clinical services with logistics in a single system.
- Kare Chemical Technologies — Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
Working with Ontario talent to develop World Class Companies Learn More
Show more...Investment focus
- Industry: Software, Health Care, Analytics
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 164
- Round size: Seed $375k–$4M; Pre-Seed $368k–$1.5M; Series A $2.3M–$14M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $8.5M in 2014
Portfolio highlights
- Azoma — Ecomtent enables brands to create eCommerce content with Generative AI. Using Ecomtent's self-service tools, customers can generate their entire optimized Amazon listing, using our AI product photo generator, AI Generate infographics at scale, a+ content, and generate optimised copy.
- SELL IT9 — Get top cash for your tech with SELLIT9, Canada's trusted trade-in service. Free same-day pickups, convenient drop-off locations, and pre-paid shipping labels nationwide. Fast, secure, and hassle-free!
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 36
- Round size: Seed $1.5M–$4M; Series A $3M–$20M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $11M in 2018
Portfolio highlights
- AI4Eyes — AI4Eyes offers an end-to-end AI software & data collection platform for fast, precise, and consistent ocular diagnostics, enabling clinicians to detect and improve eye health.
- NURA Medical — Discover NurEx's medication safety software and its novel weight estimation technology, designed for healthcare professionals. Experience easy-to-use pediatric dosing, accurate weight measurement, and streamlined formulary management to enhance patient safety and reduce medication errors. Book a demo today.
- Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
Lumira Ventures, a later stage VC, partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 122
- Round size: Series A $2.9M–$105M; Series B $12M–$75M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Nervonik — Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.
- Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we are developing targeted therapies that re-establish calm within the immune system and help rest ...
We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Pre-Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 24
- Round size: Seed $600k–$3.2M; Angel $500k–$600k; Pre-Seed $120k–$1.5M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
- Spare — Spare is your all-in-one mobility operations platform, designed to provide an end-to-end platform ecosystem for operating modern paratransit and microtransit systems.
- Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.
Show more...Investment focus
- Industry: Manufacturing, Energy, Renewable Energy
- Stage:Grant, Seed, Pre-Seed
- Geography: Canada, United States, Brazil
Investor stats
- Total investments: 265
- Round size: Seed $73k–$2.5M; Grant $772k–$7.4M; Pre-Seed $149k–$1.6M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Niricson — Niricson develops an AI-based predictive analytics SaaS platform for infrastructure asset management. Its AUTOSPEX platform and DRONIC provide asset managers and civil engineers critical insights and multi-defect layer visualization for the current condition of their assets.
- Solaires Entreprises Inc — Solaires Entreprises Inc is a Canadian cleantech company located in Victoria, BC, that consists of a team of 23 scientists, engineers, and business professionals. Solaires is focused on developing the next generation of solar cells by replacing silicon with perovskite through an innovative and sustainable manufacturing process resulting inaffordable solar photovoltaics with higher energy conversion efficiency.
- Progressive Planet Solutions — Progressive Planet Solutions Inc is a metal/mineral based company that deals with the exploration & development of zeolite minerals.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 50
- Round size: Seed $500k–$5.2M; Series A $3.9M–$17M; Venture - Series Unknown $10M–$14M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $250M in 2022
Portfolio highlights
- Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
- Exact Imaging — Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging.
- Adenocyte — Adenocyte. Early detection and prevention of pancreatic cancer.
Archangel is the overarching early stage investment fund based in Waterloo Region, the North Silicon Valley of North America.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 69
- Round size: Seed $10k–$3.8M; Pre-Seed $700k–$1.6M; Venture - Series Unknown $1.6M–$19M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — raised $10M in 2021
Portfolio highlights
- myStoria — Backed by fertility doctors. Built by patients, for patients. Track symptoms, manage diagnoses, get advice, and start moving forward.
- Streamforge — Streamforge helps companies find the most relevant creators for their games and products using the most sophisticated platform and technology on the market.
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
We support entrepreneurs at every stage of their journey and build technology companies that generate a positive impact on society.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 410
- Round size: Seed $1M–$8.3M; Series A $2.3M–$20M; Series B $5M–$65M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $300M in 2024
Portfolio highlights
- Modem — Your dev team's auto-triage Product Manager
- Cohere — Cohere builds powerful models and AI solutions enabling enterprises to automate processes, empower employees, and turn fragmented data into actionable insights.
- TripleLift — Turn fragmented media into a coordinated system. TripleLift connects data, creative, and supply to drive measurable advertising outcomes.
Afore Capital backs product-centric founders at the pre-seed stage exclusively. The investment team brings 16 years of founding product experience (Android and Twitter) and 7 years of institutional investing experience (Founder Collective and Foundation Capital). Their sweet spot is the ~$1M pre-seed round, where they can lead the round as aninstitutional investor alongside high value angels.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 267
- Round size: Seed $2.1M–$10M; Pre-Seed $500k–$3M; Series A $7M–$25M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $185M in 2025
Portfolio highlights
- CivilGrid — CivilGrid centralizes utility, environmental, geotechnical, and other site data in a SaaS platform where your teams can collaboratively scope and plan projects.
- Hypercubic — Hypercubic is agentic AI for mainframe modernization, helping enterprises and governments preserve institutional knowledge and modernize COBOL.
- Tideshiftai — TideShiftAI leverages AI to provide personalized insights and forecasts for businesses, helping them optimize operations and enhance decision-making.
Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, Australia, United States
Investor stats
- Total investments: 155
- Round size: Seed $50k–$3.1M; Grant $25k–$91k; Pre-Seed $18k–$878k
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Bright Breaks — Bright offer on-site and virtual amenities for companies and employees. whether your team is on-site, working from home, or in between.
- Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
- CarbonCure Technologies — CarbonCure Technologies creates, develops, and licenses solutions that consume waste CO2 to make better concrete. It spurs the market shift towards affordable green concrete, by enabling concrete manufacturers to convert waste CO2 into solid minerals, locked away as a solid within concrete during manufacturing. It is a green building technologycompany currently serving concrete product manufacturers in the US and Canada. It offers concrete producers the ability to manufacture green concrete products without compromising on either quality or price.CarbonCure is a retrofit innovation that repurposes CO2 gas from large final emitters as a feedstock in concrete plants. The gas is permanently converted into embedded solid mineral carbonates that yield material, environmental, and production advantages. By enabling concrete manufacturers to consume CO2 into concrete products during manufacturing, the technology differentiates an otherwise traditional commodity concrete product, while achieving superior material performance characteristics. In addition to technology, CarbonCure provides demand-pull marketing and environmental reporting/certification services to reinforce its customers’ exclusive competitive positioning. The technology is licensed at a very low-CAPEX to concrete producers, generating a recurring revenue stream.CarbonCure Technologies was founded in 2007 and is headquartered in Halifax, Nova Scotia.
We've helped 175 founders build enduring companies - and we're ready to take it to the next level.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 35
- Round size: Seed $1.1M–$4.7M; Pre-Seed $729k–$6M; Series A $7.3M–$31M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $92M in 2023
Portfolio highlights
- myStoria — Backed by fertility doctors. Built by patients, for patients. Track symptoms, manage diagnoses, get advice, and start moving forward.
- InsideDesk — Reduce AR days, boost collections, and streamline billing operations with InsideDesk's centralized revenue cycle management platform.
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
BDC Capital Women in Technology (WIT) Fund is one of the world’s largest venture capital funds
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Canada
Investor stats
- Total investments: 35
- Round size: Series A $2.9M–$83M; Series B $13M–$200M; Venture - Series Unknown $2.6M–$42M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Waabi — Waabi operates as a self-driving technology start-up. Waabi is bringing the promise of self-driving closer to commercialization than ever before.
- Swift Medical — Get advanced wound care powered by AI with Swift. 32M+ calibrated images enable 35% faster healing, 79% faster assessments, and 15% fewer hospitalizations.
- Eigen Innovations — Eigen combines imaging and AI to detect issues traditional vision systems miss, revolutionizing quality inspection.
WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Canada
Investor stats
- Total investments: 77
- Round size: Seed $100k–$3.8M; Pre-Seed $279k–$1.5M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- Carbonyx — Carbonyx transforms waste into carbon-negative advanced materials for industry.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $766k–$3.3M; Series A $1.1M–$4.5M; Venture - Series Unknown $709k–$12M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $117k in 2024
Portfolio highlights
- Derapi — Derapi is a universal API for distributed energy resource (DER) devices, including solar, battery storage, EV chargers, smart thermostats, heat pumps, and other behind-the-meter loads. Derapi unlocks the full value of DERs by removing bottlenecks related to data integration, reducing data infrastructure costs and speeding time to market for DERsoftware developers, DER device manufacturers, and others in the DER ecosystem.
- GridBank — Enhance Your Social Media Engagement And Following With Stunning User-Generated Videos. Access A Wide Range Of Royalty-Free Stock Videos For Various Themes Including Travel, Productivity, Aesthetic Backgrounds, And More
- Trolley — Trolley is the best payouts platform for businesses needing to pay creators, musicians, artists, freelancers, or on-demand workers.
OrganiGram is a producer and distributor of medical and recreational cannabis. They are dedicated to consistently providing clients with the highest grade medicine and service. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international businesspartnerships to extend the Company’s global footprint.
Show more...Investment focus
- Industry: Cannabis, Biotechnology, Medical
- Stage:Convertible Note, Series B, Debt Financing
- Geography: Canada, United States, Germany
Investor stats
- Total investments: 12
- Round size: Convertible Note $1M–$12M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Sanity Group — Sanity Group is a holistic European Cannabis company focusing on health, wellbeing, and scientific research. To utilize the full potential of its health benefits, Sanity Group is investing in fundamental research of the cannabis plant and its active ingredients as well as in specific areas of application.It was founded in 2018 and headquarteredin Berlin, Germany.
- Phylos — Revolutionary cannabis seed varieties with outstanding traits that have been bred to grow uniformly like clones.
- Open Book Extracts — Premium wholesale cannabinoid supplier offering CBD, CBN, CBG, CBC, and THCV isolates. Water-soluble formulations for beverages. Custom formulation services. GMP-certified, research-backed cannabinoids.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Next-generation venture capital. Write your story with us.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $3M–$23M; Pre-Seed $500k–$8.1M; Series B $24M–$130M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Clario — Clario identifies and eliminates redundant, obsolete, and trivial unstructured data so organizations reduce waste, lower risk, and create cleaner foundations for AI.
- Inner Logic — The development infrastructure for the next generation of procedural devices.
- Integrated Biosciences — Integrated Biosciences is the first company in history to be able to virtually stress cells.
Hazelview Ventures provide entrepreneurs with a unique opportunity to refine, scale, and showcase product and service capabilities.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Big Data
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, Slovakia (Slovak Republic)
Investor stats
- Total investments: 7
- Round size: Seed $2M–$12M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Xaba — Xaba develops intelligent automation solutions, materials and processes to enable a world of sustainable manufacturing.
- Lamarr.AI — Saving Energy Through Automated Building Exterior Inspection AI-powered envelope diagnostics to accelerate the transition to Net Zero buildings. Contact Us About Lamarr.AI Defining pathways for future cities by developing technology innovations Lamarr.AI entered the market in 2023 as the product
- SensorSuite — A Complete Suite Of Monitoring And Control Solutions For Your Boilers & Electrically Heated Buildings
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $1.3M–$9.5M; Pre-Seed $281k–$2M; Series A $744k–$115M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Thred — Thred is the first B2B Intent platform designed for AI. Act on accounts researching in ChatGPT, Gemini, and Claude.
Since 1980, WTI has helped more than 1,300 companies across every innovation sector finance their growth while minimizing dilution.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Nigeria
Investor stats
- Total investments: 319
- Round size: Seed $1M–$10M; Series A $3M–$21M; Series B $5M–$100M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $375M in 2013
Portfolio highlights
- Meta — At Meta, they work on landmark AI challenges that have the power to transform how scientific knowledge is experienced and consumed. Meta provides innovators throughout the scientific ecosystem with powerful views of the current and future trajectories of science and technology with the goal of making all scientific knowledge computable. Meta’smission is to unlock all of the world’s scientific and technical insights using artificial intelligence.
- RightsFlow — RightsFlow is a leading technology-enabled provider of mechanical licensing and royalty accounting, reporting, and payment services for online music companies, record companies, distributors, artists, and songwriters. The RightsFlow technology powers rapid song identification and provides an unprecedented level of transparency for both licenseesand licensors. RightsFlow specializes in obtaining bulk physical, DPD, and ringtone licenses including streaming, tethered, and limited download rights. Our proprietary licensing technology and 30+ million song database allow us to license content, render accounting, and pay royalties on behalf of clients quickly and accurately, ensuring that rights-holders are paid for the use of their work. RightsFlow was acquired by Google in 2011 and is now part of the team at YouTube helping to simplify music licensing, content identification, accounting and payments for songwriters and publishers worldwide.
- Prosper Medical — Prosper Medical is a telemedicine platform that connects members with physicians for personalized healthcare services.
Scale Good Fund is a Social Impact Venture Capital VC fund that invests in companies who have the promise of a strong financial return coupled with measurable social impact goals.
Show more...Investment focus
- Industry: Health Care, Wellness, Apps
- Stage:Seed, Pre-Seed
- Geography: Canada
Investor stats
- Total investments: 10
- Round size: Seed $1.1M–$8.7M; Pre-Seed $37k–$1.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- NiaHealth — Get advanced at-home biomarker testing, proactive healthspan diagnostics, and expert guidance to elevate your health. HSA-eligible.
- Ultimarii —
- PulseMedica — PulseMedica is developing a medical device to treat eye diseases that affect over 500 million people worldwide. Our device consists of a state-of-the-art 3D imaging and surgical platform that allows for comprehensive patient treatment.
Tom Williams
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 116
- Round size: Seed $1.3M–$6M; Series A $7.9M–$32M; Series B $10M–$57M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Unito — Unito is taking on a major problem that people are passionate about solving: they make it easier to collaborate across teams. They don't make users learn new tools and change the way they work. By connecting work management tools, they allow managers, cross-functional teams, departments, and entire companies to benefit from seamlesscollaboration and improved communication. The app syncs projects across a number of tools like Trello, Asana, JIRA, GitHub, Wrike, Zendesk & Hubspot. This is a hard problem of semantics, synchronization, and APIs.
- Delphia — Delphia puts your data to work for you.
- North One — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.
LVL1 Group is a private investment management firm, operating across different asset classes and geographies. We were founded with entrepreneurial spirit at our core, with a natural passion for venture investing, working closely with founders to forge meaningful strategic relationships and helping them to succeed. We are not bound by mandates andinvestment periods, which allows us to be flexible and opportunistic. We look for companies that aim to make a strong global impact, particularly in Online Travel, Gaming, eSports, Content and Community Platforms.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Convertible Note
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $577k–$10M; Series A $2M–$39M; Convertible Note $500k–$46M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- GRACIA.AI — Volumetric video production powered by 4D Gaussian Splatting (4DGS). From multi-camera capture to delivery in any engine, browser, or headset.
- Native Commerce — Grow your business with Jiffy SaaS platform which includes app/website, picking, delivery, supply chain & replenishment services
- Native Commerce — A unified e-commerce platform combining CMS, OMS, WMS, Delivery & Logistics to help modern retailers operate, scale & deliver great e-commerce experiences.
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 363
- Round size: Seed $604k–$9.5M; Series A $4.5M–$22M; Series B $7M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely actively investing — fresh fund, raised $230k in 2026
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Toyota Ventures is a San Francisco Bay Area-based venture capital firm that invests in early-stage startups from around the world. Founded in July 2017, its mission is to discover what’s next for Toyota by helping startups bring disruptive technologies and business models to market quickly. With more than $800 million in assets under management,the firm’s funds include the Toyota Ventures Frontier Fund focused on artificial intelligence, cloud computing, autonomy, mobility, robotics, financial technologies, materials, and energy; and the Toyota Ventures Climate Fund focused on innovative solutions for carbon neutrality.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Robotics
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 154
- Round size: Seed $1.4M–$17M; Series A $9.3M–$38M; Series B $15M–$126M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $150M in 2024
Portfolio highlights
- River — Empowering people, improving lives.
- Walden Robotics — Walden Robotics is an industrial robotics company that builds and deploys general-purpose, semi-humanoid robots for manufacturing and logistics.
- Supercritical — We partner with industry to move and think beyond fossil fuels with innovative clean technology solutions.
Killick Capital is a leading Atlantic Canadian private equity firm, dedicated to partnering with Atlantic Canadian businesses and Aerospace businesses. Our team of professionals work closely with portfolio companies to maximize success.
Show more...Investment focus
- Industry: Software, Health Care, Aerospace
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 54
- Round size: Seed $525k–$10M; Pre-Seed $213k–$1.3M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- CoLab Software — The only tool purpose-built to simplify design reviews for engineering teams building complex products.
- Avalon Holographics — Avalon Holographics is designing next-generation holographic displays for commercial and consumer applications. The company is leading the next wave of display technology with light field displays that revolutionize the way people produce, view, and understand visual content. By replicating the experience of looking at real objects, Avalon’sdisplays produce realistic, comfortable, and accessory-free experiences.
- Sparrow BioAcoustics — Sparrow BioAcoustics ,developers of a smartphone stethoscope designed to gather and collaborate on medical-grade cardiac and pulmonary data.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, Canada, France
Investor stats
- Total investments: 21
- Round size: Seed $566k–$18M; Series A $1.3M–$41M; Venture - Series Unknown $3.6M–$20M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Icentia — Icentia provides a range of innovative medical tests for healthcare institutions. They are able to offer valuable solutions for major problems in the field of medical testing.
- Simmunome AI — We use AI to create accurate, comprehensive disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to gain insights, make go/no-go decisions, and de-risk your pipeline, getting you to market faster and reducing your R&D co
- Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
Bee Partners, a preSeed venture capital fund, partners with Founders with the smarts, grit, and humanity to create tomorrow's machines. We invest in three vectors: Human Machine Interaction, Machine-to-Machine Learning, and Biological Machines.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 137
- Round size: Seed $1.2M–$5.5M; Pre-Seed $500k–$3.1M; Series A $4.6M–$25M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Octave — The context engine for Growth and GTM engineering teams
- Drafter — automating go to manufacturing
- C-Infinity — Pioneering AI for mechanical design and manufacturing. Our product, AutoAssembler, provides breakthrough assembly intelligence for complex physical systems.
Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 43
- Round size: Seed $931k–$2.1M; Pre-Seed $48k–$770k
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
- Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
- Possibility Neurotechnologies — Connecting hearts and minds while fostering community through simple, accessible brain-controlled technology. #BCIs #assistivetech #inclusion
Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 187
- Round size: Series A $10M–$100M; Series B $20M–$120M; Series C $15M–$102M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $600M in 2018
Portfolio highlights
- Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.
- Flare Therapeutics — Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets fortranscription factor regulation to address mutations that cause disease. Its drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
- Flexion Therapeutics — Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
Brigus Capital is a privately-owned investment company focused on investing in small-cap publicly traded companies and select privately owned companies.
Show more...Investment focus
- Industry: Mining, Mineral, Health Care
- Stage:Private Equity, Post-IPO Equity, Seed
- Geography: Canada, United States
Investor stats
- Total investments: 10
- Round size: Post-IPO Equity $332k–$700k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Antler Gold — Antler Gold Inc. (TSXV: ANTL) is a Canadian gold exploration company, focused on projects in Namibia.
- Coloursmith Labs Inc. — Coloursmith develops breakthrough optical filtering technologies in ophthalmic devices.
- ReeXploration — E-Tech Resources is an exploring and development business with a focus on REE.
We partner with future literate entrepreneurs who understand our unique time and place in history, with the ambition to author a better future for humanity.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Health Diagnostics
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 49
- Round size: Seed $1.6M–$6M; Series A $5M–$32M; Series B $12M–$53M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Arzeda — Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable.
- A-Alpha Bio — Measure more protein interactions
- Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.
Gradient is a seed fund that focuses on supporting founders in the artificial intelligence sector. The firm collaborates closely with innovators to integrate AI into various business processes and drive technological advancements. Gradient aims to foster disruptive ideas that can redefine industries and enhance operational capabilities.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 382
- Round size: Seed $2.5M–$9.2M; Series A $8.2M–$27M; Series B $20M–$68M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fresh fund, raised $220M in 2026
Portfolio highlights
- Arga Labs — Arga Labs develops software testing and validation infrastructure for AI agents and applications. The company provides real-world sandbox environments that replicate third-party services, APIs, command-line interfaces, and MCPs, allowing developers to test software without affecting production systems. Its platform provides digital twins, isolatedsandboxes, production-informed scenarios, automated test runs, and detailed evidence of provider calls, responses, latency, and side effects. Arga also supports pull request validation, browser-based testing, security testing, and autonomous agent testing through deterministic environments. The platform integrates with development and observability tools such as GitHub, Jira, Linear, Sentry, and PostHog to incorporate application context into testing workflows. Arga Labs serves software development teams building applications and AI agents that interact with external services.
- Axle Labs — Axle is an open platform for consumer-permissioned insurance data. With Axle, companies can instantly verify insurance and monitor ongoing coverage, helping them create a frictionless experience for their customers and reduce operational risk through better-informed decisions.
- Truthsystems — Truth Systems offers real-time compliance agents that prevent human error by embedding behavioral guardrails into AI interactions.
Builders VC is an early-stage venture capital firm focused on investing where technology meets new business models to modernize antiquated industries including healthcare, agriculture, industrials and real-estate.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 103
- Round size: Seed $1.8M–$11M; Series A $6M–$21M; Series B $8M–$39M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $250M in 2022
Portfolio highlights
- AuX Labs — No compromise between taste and what you care about. A capital-efficient platform delivering the proteins that give dairy its magic.
- Askari Defense — Intelligent Kinetic Defense For the Age of Robotic Warfare
- Ichor Microbial Solutions — Ichor Microbial Solutions is a company that offers agricultural services.
Invest in transformational technologies that can achieve large scale solutions globally.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Education
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, India
Investor stats
- Total investments: 44
- Round size: Seed $1.2M–$5M; Pre-Seed $1.2M–$2.5M; Series A $7.3M–$28M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $22M in 2020
Portfolio highlights
- Fex Energy — FeX Energy is a pre-commercial startup focused on developing renewable energy storage solutions.
- ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.
- Carbon Upcycling — Our cities, roads, energy, AI, and all critical infrastructure are built on a foundation of concrete. And cement is the glue that holds it all together. Securing our tomorrow means securing our critical cement materials. It means building manufacturing independence, localizing supply chains, and investing...
Purveyors of warm vibes and cold cash since 2015.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed
- Geography: United States, Canada
Investor stats
- Total investments: 64
- Round size: Seed $750k–$9M; Pre-Seed $125k–$3.2M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $650k in 2019
Portfolio highlights
- Kaaj AI — Unlock faster, profitable small business lending with Agentic AI
- Ergo — Ergo turns conversations into automatic follow-ups, CRM updates, coaching, and forecasting. Reps spend less time on admin work, deals stop slipping.
- Falconer — The self-driving knowledge base. Replace Confluence, Google Docs, and useless meetings.
Life Science Investor funding in Canada at a glance
Stats across 308 deals from 385 investors.
Access all 385 investors in Canada Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 385 investors investing in Canada Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!